Overview
What is The Boston Pathology Course Incorporated?
The Boston Pathology Course Incorporated is a not-for-profit organization situated in Merrimac, Massachusetts. Their primary objective is to offer educational services, focusing on diseases and disorders. They function as a professional society dedicated to this cause, serving as a platform for knowledge exchange and advancement in the field. By providing educational resources, they aim to contribute to the broader medical community and the understanding of various pathologies.
Is The Boston Pathology Course Incorporated legitimate?
The Boston Pathology Course Incorporated is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Boston Pathology Course Incorporated submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
What is the mission statement of The Boston Pathology Course Incorporated?
The Boston Pathology Course Incorporated is a non-profit organization with a mission centered around educational services. Their primary objective is to contribute to the field of disease or disorder focused professional societies. By focusing on education, they aim to make a significant impact and contribute positively to their respective field.
Who is the CEO of The Boston Pathology Course Incorporated?
Unavailable
What is the revenue of The Boston Pathology Course Incorporated?
The Boston Pathology Course Incorporated's revenue in 2020 was $13,500.
Who are the executives of The Boston Pathology Course Incorporated and what are their salaries?
There is 1 key member and their salary:
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990EZ for The Boston Pathology Course Incorporated?
The Boston Pathology Course Incorporated's most recent form 990EZ was submitted in 2020 and can be accessed here.
Mission Statement of The Boston Pathology Course Incorporated
The Boston Pathology Course Incorporated, as a non-profit educational organization, is dedicated to serving the field of pathology by providing educational resources. Their primary mission is to contribute positively to this sector, operating under a non-profit framework. This esteemed organization is committed to advancing knowledge and understanding in the field of pathology through educational services.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
August, 2024
The Boston Pathology Course Incorporated has had a significant impact on the field of pathology through its provision of high-quality educational services focused on diseases and disorders. Its mission to offer non-profit educational resources has helped to enhance the knowledge and skills of professionals in this specialized area, ultimately contributing to improved patient care and outcomes. The organization's dedication to educational excellence has set a standard for pathology education and training, benefiting individuals and institutions in the medical community.
This information is meant to be a general summary of The Boston Pathology Course Incorporated. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2020.
- Gross Receipts: $13,500
Assets and Liabilities:
- Total Assets: $1,081
- Total Liabilities: $0
- Net Assets: $1,081
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
If you are a representative of The Boston Pathology Course Incorporated and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.